Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People
- PMID: 26693921
- DOI: 10.1007/s40266-015-0337-y
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People
Abstract
Aims: The objective of this study was to evaluate the prevalence of the prescription of QT-prolonging drugs at hospital admission and discharge and the risk factors associated with their use in older people (aged 65 years and older).
Methods: Data were obtained from the REPOSI (REgistro POliterapie SIMI [Società Italiana di Medicina Interna]) registry, which enrolled 4035 patients in 2008 (n = 1332), 2010 (n = 1380), and 2012 (n = 1323). Multivariable logistic regression was performed to determine the risk factors independently associated with QT-prolonging drug use. QT-prolonging drugs were classified by the risk of Torsades de Pointes (TdP) (definite, possible, or conditional) according to the Arizona Center for Education and Research on Therapeutics (AzCERT) classification. Specific drug combinations were also assessed.
Results: Among 3906 patients prescribed at least one drug at admission, 2156 (55.2%) were taking at least one QT-prolonging drug. Risk factors independently associated with the use of any QT-prolonging drugs were increasing age (odds ratio [OR] 1.02, 95% CI 1.01-1.03), multimorbidity (OR 2.69, 95% CI 2.33-3.10), hypokalemia (OR 2.79, 95% CI 1.32-5.89), atrial fibrillation (OR 1.66, 95% CI 1.40-1.98), and heart failure (OR 3.17, 95% CI 2.49-4.05). Furosemide, alone or in combination, was the most prescribed drug. Amiodarone was the most prescribed drug with a definite risk of TdP. Both the absolute number of QT-prolonging drugs (2890 vs. 3549) and the number of patients treated with them (2456 vs. 2156) increased at discharge. Among 1808 patients not prescribed QT-prolonging drugs at admission, 35.8% were prescribed them at discharge.
Conclusions: Despite their risk, QT-prolonging drugs are widely prescribed to hospitalized older persons. The curriculum for both practicing physicians and medical students should be strengthened to provide more education on the appropriate use of drugs in order to improve the management of hospitalized older people.
Similar articles
-
Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data.Drug Saf. 2017 Feb;40(2):133-144. doi: 10.1007/s40264-016-0477-y. Drug Saf. 2017. PMID: 27896662
-
Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.Drug Saf. 2012 Jun 1;35(6):459-70. doi: 10.2165/11598160-000000000-00000. Drug Saf. 2012. PMID: 22612851
-
High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia.Br J Clin Pharmacol. 2016 Aug;82(2):504-11. doi: 10.1111/bcp.12969. Epub 2016 May 21. Br J Clin Pharmacol. 2016. PMID: 27060989 Free PMC article.
-
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.Curr Med Res Opin. 2013 Dec;29(12):1719-26. doi: 10.1185/03007995.2013.840568. Epub 2013 Sep 23. Curr Med Res Opin. 2013. PMID: 24020938 Review.
-
Drug-induced torsades de pointes in patients aged 80 years or more.Anadolu Kardiyol Derg. 2008 Aug;8(4):260-5. Anadolu Kardiyol Derg. 2008. PMID: 18676301 Review.
Cited by
-
Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine.Drugs Real World Outcomes. 2021 Sep;8(3):325-335. doi: 10.1007/s40801-021-00234-x. Epub 2021 Apr 8. Drugs Real World Outcomes. 2021. PMID: 33834380 Free PMC article.
-
Rapid changes of mRNA expressions of cardiac ion channels affected by Torsadogenic drugs influence susceptibility of rat hearts to arrhythmias induced by Beta-Adrenergic stimulation.Pharmacol Res Perspect. 2023 Oct;11(5):e01134. doi: 10.1002/prp2.1134. Pharmacol Res Perspect. 2023. PMID: 37715323 Free PMC article.
-
Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders.Ann Transl Med. 2018 Apr;6(8):147. doi: 10.21037/atm.2018.03.17. Ann Transl Med. 2018. PMID: 29862236 Free PMC article.
-
Effects of antidepressants on QT interval in people with mental disorders.Arch Med Sci. 2020 May 29;16(4):727-741. doi: 10.5114/aoms.2019.86928. eCollection 2020. Arch Med Sci. 2020. PMID: 32542073 Free PMC article. Review.
-
TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY.Acta Clin Croat. 2019 Dec;58(4):751-756. doi: 10.20471/acc.2019.58.04.23. Acta Clin Croat. 2019. PMID: 32665746 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources